Litcius/Paper detail

Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda

Daniel Lule Bugembe, John Kayiwa, My V. T. Phan, Phionah Tushabe, Stephen Balinandi, Beatrice Dhaala, Jonas Lexow, Henry Mwebesa, Jane Ruth Aceng, Henry Kyobe, Deogratius Ssemwanga, Julius J. Lutwama, Pontiano Kaleebu, Matthew Cotten

2020Emerging infectious diseases39 citationsDOIOpen Access PDF

Abstract

S evere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1,2), the cause of coronavirus disease (COVID-19), has been spreading globally since it was first reported in Wuhan, China, on December 30, 2019 (3,4), infecting >10 million persons and causing massive disruption of daily lives and substantial economic consequences (5). Given the expanding pandemic and the absence of effective vaccines and antiviral drugs, the best strategy to control the spread of SARS-CoV-2 might be testing, contact tracing, and quarantining. Early implementation of diagnostic testing enables contact tracing and quarantining to reduce transmission in the community and can protect limited healthcare resources.

Topics & Concepts

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirus disease 2019 (COVID-19)Transmission (telecommunications)BiologyCoronavirus2019-20 coronavirus outbreakVirusDiversity (politics)Genetic diversitySars virusEvolutionary biologyGeneticsMedicineEnvironmental healthPolitical scienceOutbreakPopulationInfectious disease (medical specialty)LawEngineeringDiseasePathologyElectrical engineeringSARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesAnimal Virus Infections Studies